Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing

One of the most serious side effects of diabetes is diabetic foot ulceration (DFU). It is a severe and extremely morbid illness that has been linked to higher mortality on its own. The development of effective wound therapeutics in the future may be influenced by our current and developing understan...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Meiliana, Nurrani Mustika Dewi, Andi Wijaya
Format: Article
Language:English
Published: Secretariat of The Indonesian Biomedical Journal 2024-12-01
Series:Indonesian Biomedical Journal
Online Access:https://inabj.org/index.php/ibj/article/view/3407
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841558872365465600
author Anna Meiliana
Nurrani Mustika Dewi
Andi Wijaya
author_facet Anna Meiliana
Nurrani Mustika Dewi
Andi Wijaya
author_sort Anna Meiliana
collection DOAJ
description One of the most serious side effects of diabetes is diabetic foot ulceration (DFU). It is a severe and extremely morbid illness that has been linked to higher mortality on its own. The development of effective wound therapeutics in the future may be influenced by our current and developing understanding of wound pathophysiology. By reestablishing cellular functioning, small extracellular vesicles (sEVs), a crucial medium for intercellular communications, exhibit encouraging therapeutic potential in the treatment of DFU. Mesenchymal stem cell (MSC) derived exosomes and engineered extracellular vesicles (EVs) have the potential to aid in the healing of wounds. Along with encouraging the growth and stimulation of endothelial cells, keratinocytes, and fibroblasts, they also have immunomodulatory and anti-inflammatory properties. They help prevent damaged cells from dying, revitalize senescent cells, and boost angiogenesis. MSC-EVs can be a safe, effective and ethical therapy for DFU by increasing M2 macrophages polarization, improving the proliferation, reducing scar, and improving angiogenesis. KEYWORDS: mesenchymal stem cell, extracellular vesicle, diabetic wound, wound healing
format Article
id doaj-art-d2523b74351345d4aff3eda634a60c9c
institution Kabale University
issn 2085-3297
2355-9179
language English
publishDate 2024-12-01
publisher Secretariat of The Indonesian Biomedical Journal
record_format Article
series Indonesian Biomedical Journal
spelling doaj-art-d2523b74351345d4aff3eda634a60c9c2025-01-06T02:04:18ZengSecretariat of The Indonesian Biomedical JournalIndonesian Biomedical Journal2085-32972355-91792024-12-0116648750910.18585/inabj.v16i6.3407603Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound HealingAnna Meiliana0Nurrani Mustika Dewi1Andi Wijaya2Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjajaran, Jl. Raya Bandung, Sumedang Km. 21, Jatinangor 45363Prodia Education and Research Institute, Jl. Kramat Raya No. 150, Jakarta, 10430Prodia Clinical Laboratory, Jl. Supratman No 43, Bandung 40114One of the most serious side effects of diabetes is diabetic foot ulceration (DFU). It is a severe and extremely morbid illness that has been linked to higher mortality on its own. The development of effective wound therapeutics in the future may be influenced by our current and developing understanding of wound pathophysiology. By reestablishing cellular functioning, small extracellular vesicles (sEVs), a crucial medium for intercellular communications, exhibit encouraging therapeutic potential in the treatment of DFU. Mesenchymal stem cell (MSC) derived exosomes and engineered extracellular vesicles (EVs) have the potential to aid in the healing of wounds. Along with encouraging the growth and stimulation of endothelial cells, keratinocytes, and fibroblasts, they also have immunomodulatory and anti-inflammatory properties. They help prevent damaged cells from dying, revitalize senescent cells, and boost angiogenesis. MSC-EVs can be a safe, effective and ethical therapy for DFU by increasing M2 macrophages polarization, improving the proliferation, reducing scar, and improving angiogenesis. KEYWORDS: mesenchymal stem cell, extracellular vesicle, diabetic wound, wound healinghttps://inabj.org/index.php/ibj/article/view/3407
spellingShingle Anna Meiliana
Nurrani Mustika Dewi
Andi Wijaya
Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
Indonesian Biomedical Journal
title Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
title_full Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
title_fullStr Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
title_full_unstemmed Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
title_short Mesenchymal Stem Cell–derived Extracellular Vesicles: An Emerging Therapeutic Strategy for Diabetic Wound Healing
title_sort mesenchymal stem cell derived extracellular vesicles an emerging therapeutic strategy for diabetic wound healing
url https://inabj.org/index.php/ibj/article/view/3407
work_keys_str_mv AT annameiliana mesenchymalstemcellderivedextracellularvesiclesanemergingtherapeuticstrategyfordiabeticwoundhealing
AT nurranimustikadewi mesenchymalstemcellderivedextracellularvesiclesanemergingtherapeuticstrategyfordiabeticwoundhealing
AT andiwijaya mesenchymalstemcellderivedextracellularvesiclesanemergingtherapeuticstrategyfordiabeticwoundhealing